Method of treatment using fused aromatic compounds having anti-diabetic activity

Details for Australian Patent Application No. 2008248186 (hide)

Owner Merck & Co., Inc.

Inventors Meinke, Peter T.; Denker, Andrew; Charnick, Steven; Meininger, Gary E.; Wagner, John A.; Uemura, Naoto

Agent Spruson & Ferguson

Pub. Number AU-A-2008248186

PCT Pub. Number WO2008/137105

Priority 60/927,949 07.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/42 (2006.01) - Oxazoles

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/137105 Priority application(s): WO2008/137105

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008248188-Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions

2008248181-Toilet bowl cleaning and/or deodorizing device